The CSTL’s vision is to conduct groundbreaking research on Castleman disease and other cytokine storms to identify optimal treatments and provide world-class patient care.
The CSTL’s mission is to conduct groundbreaking translational research on Castleman disease, COVID-19, and other cytokine storms to discover novel diagnostic biomarkers and therapeutics, identify optimal treatment approaches, and provide world-class patient care.
The CSTL pursues its mission through basic & translational research, clinical research (ACCELERATE Natural History Registry; CORONA: COvid19 Registry of Off-Label & New Agents), clinical trials (NCT03933904), and multi-disciplinary patient care.